Genesys Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 5
Professionals
  • Investments
  • 56
  • Portfolio
  • 11
  • Exits
  • 23
Exits

Genesys Capital General Information

Description

Founded in 2000, Genesys Capital is a venture capital firm based in Toronto, Ontario. The firm accelerates the development of companies by investing in seed, early stage, later stages. The firm seeks to invest in companies based in the United States and Canada and operating in the life sciences, biopharmaceuticals, medical devices, and healthcare service sectors.

Contact Information

Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 123 Front Street West
  • Suite 1503, Post Office Box 34
  • Toronto, Ontario M5J 2M2
  • Canada
+1 (416) 000-0000

Genesys Capital Investments (56)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Giiant Pharma 30-Jun-2021 Seed Round 000.00 Drug Discovery Pre-Clinical Trials 00000 00000
0000000 0000000000 16-Jun-2021 00000 00000 000.00 Drug Discovery Generating Revenue 00000 00000
000000000 0000000 02-Feb-2021 00000 00000 0000 Monitoring Equipment Generating Revenue 000000 0000
000000000 08-Sep-2020 00000 00000 0000 Drug Discovery Clinical Trials - General 00000 00000
000 0000000 19-Nov-2019 00000 00000 0000 Drug Discovery Clinical Trials - General 00000 00000
0000000 31-Oct-2019 00000 00000 000.00 Biotechnology Generating Revenue
000000 00000000000 25-Mar-2019 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1
000000000 25-Jul-2018 00000 00000 00.000 Drug Discovery Clinical Trials - General 00000 00000
Flosonics Medical 15-Jan-2018 Seed Round 00.000 Monitoring Equipment Generating Revenue 000000 0000
Adapsyn 09-Jan-2018 Early Stage VC Biotechnology Generating Revenue 00000 000000
You’re viewing 10 of 56 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genesys Capital Exits (23)

Company Name Exit Date Exit Type Exit Size
Profound Medical 21-Jul-2020 Public Investment 2nd Offering 000.00
000000000 00000000 17-Jul-2020 000000000000000000 00.000
000000 00000000000 26-Jun-2020 000 00000
0000000000 07-Jan-2020 0000000000
0000000 21-Jun-2018 000 00000
000000 28-Aug-2015 000000000000000000 00.000
0000000 12-Feb-2015 000 00000
00000000 000000 01-Jan-2015 000000000000000000 00.000
Blue Balloon Health Services 07-Jul-2014 Merger/Acquisition
Affinium Pharmaceuticals 11-Feb-2014 Merger/Acquisition
You’re viewing 10 of 23 exits. Get the full list »

Genesys Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Genesys Capital Team (10)

Name Title Deals Funds Boards Office
Damian Lamb Co-Founder & Managing Director 00 0 0 Toronto, Canada
Kelly Holman Co-Founder & Managing Director 0 0 0 Toronto, Canada
Jamie Stiff Managing Director 00 0 0 Toronto, Canada
Kenneth Galbraith Venture Partner Toronto, Canada
Jennifer Williams Director of Finance and Operations Toronto, Canada
You’re viewing 5 of 10 team members. Get the full list »

Genesys Capital Co-Investors (46)

Name With Exits Lead Partner Series Industry
Accel-Rx 2 0 Series chart Industry bar
Anges Québec 0 0 Series chart Industry bar
Anges Québec Capital 0 0 Series chart Industry bar
Fonds de solidarité FTQ 0 0 Series chart Industry bar
GeneChem 0 0 Series chart Industry bar
You’re viewing 5 of 46 co-investors. Get the full list »